These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10076002)

  • 41. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activities of tRNA-embedded dimeric minizymes.
    Kuwabara T; Warashina M; Nakayama A; Ohkawa J; Taira K
    Nucleic Acids Symp Ser; 1997; (37):307-8. PubMed ID: 9586122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-magnesium, trans-cleavage activity by type III, tertiary stabilized hammerhead ribozymes with stem 1 discontinuities.
    Burke DH; Greathouse ST
    BMC Biochem; 2005 Aug; 6():14. PubMed ID: 16095542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimal Hammerhead Ribozymes with Uncompromised Catalytic Activity.
    O'Rourke SM; Estell W; Scott WG
    J Mol Biol; 2015 Jul; 427(14):2340-7. PubMed ID: 25981451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction.
    Murray JB; Dunham CM; Scott WG
    J Mol Biol; 2002 Jan; 315(2):121-30. PubMed ID: 11779233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intermolecular cleavage by the newt ribozyme.
    Marusic L; Luzi E; Barsacchi G; Eckstein F
    Eur J Biochem; 1997 Jul; 247(1):396-401. PubMed ID: 9249052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of viral multiplication in acute and chronic stages of infection by ribozymes targeted against the polymerase gene of mouse hepatitis virus.
    Maeda A; Mizutani T; Hayashi M; Ishida K; Watanabe T; Namioka S
    Adv Exp Med Biol; 1995; 380():399-404. PubMed ID: 8830515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.
    Thompson JD; Ayers DF; Malmstrom TA; McKenzie TL; Ganousis L; Chowrira BM; Couture L; Stinchcomb DT
    Nucleic Acids Res; 1995 Jun; 23(12):2259-68. PubMed ID: 7610054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ribozyme mediated destruction of influenza A virus in vitro and in vivo.
    Tang XB; Hobom G; Luo D
    J Med Virol; 1994 Apr; 42(4):385-95. PubMed ID: 8046429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.
    Chang Z; Westaway S; Li S; Zaia JA; Rossi JJ; Scherer LJ
    Mol Ther; 2002 Oct; 6(4):481-9. PubMed ID: 12377189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.
    Shimayama T; Nishikawa F; Nishikawa S; Taira K
    Nucleic Acids Res; 1993 Jun; 21(11):2605-11. PubMed ID: 8332458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
    Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of hammerhead ribozymes containing non-nucleotidic linkers.
    Thomson JB; Tuschl T; Eckstein F
    Nucleic Acids Res; 1993 Dec; 21(24):5600-3. PubMed ID: 7506829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substitution of non-catalytic stem and loop regions of hammerhead ribozyme with DNA counterparts only increases KM without sacrificing the catalytic step (kcat): a way to improve substrate-specificity.
    Shimayama T; Sawata S; Komiyama M; Takagi Y; Tanaka Y; Wada A; Sugimoto N; Rossi JJ; Nishikawa F; Nishikawa S
    Nucleic Acids Symp Ser; 1992; (27):17-8. PubMed ID: 1283905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing.
    Lange MJ; Sharma TK; Whatley AS; Landon LA; Tempesta MA; Johnson MC; Burke DH
    Mol Ther; 2012 Dec; 20(12):2304-14. PubMed ID: 22948672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient ligation of the Schistosoma hammerhead ribozyme.
    Canny MD; Jucker FM; Pardi A
    Biochemistry; 2007 Mar; 46(12):3826-34. PubMed ID: 17319693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
    Sioud M; Jespersen L
    J Mol Biol; 1996 Apr; 257(4):775-89. PubMed ID: 8636981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.